نتایج جستجو برای: thiopurine methyl transferase

تعداد نتایج: 139474  

Journal: :Drug metabolism and disposition: the biological fate of chemicals 2001
R Weinshilboum

Thiopurine drugs are used to treat patients with neoplasia and autoimmune disease as well as transplant recipients. These agents are metabolized, in part, by S-methylation catalyzed by thiopurine methyltransferase (TPMT). The discovery nearly two decades ago that levels of TPMT activity in human tissues are controlled by a common genetic polymorphism led to one of the best examples of the poten...

Journal: :Clinical chemistry 1998
T Dervieux R Boulieu

6-thioguanine (6-TGN) and methyl 6-mercaptopurine nucleotides (Me6-MPNs) are the two major metabolites found in erythrocytes after administration of azathioprine. In an attempt to understand the role of these metabolites in the pharmacologic and toxic activity of thiopurines, we have developed a HPLC method for the simultaneous determination of 6-TGNs and Me6-MPNs in erythrocytes. A simple and ...

2017
M M T J Broekman M J H Coenen G J Wanten C J van Marrewijk O H Klungel A L M Verbeek P M Hooymans H-J Guchelaar H Scheffer L J J Derijks D R Wong D J de Jong

BACKGROUND Leucopenia is a common side effect in patients treated with thiopurines. Variants in the thiopurine S-methyltransferase (TPMT) gene are the best-known risk factor, but only explain up to 25% of leucopenia cases. AIM To identify the clinical risk factors for thiopurine-induced leucopenia in patients without a common TPMT variant, and explore if these patients are at increased risk f...

Journal: :Pharmacogenomics 2006
M Elske van den Akker-van Marle David Gurwitz Symone B Detmar Christine M Enzing Michael M Hopkins Emma Gutierrez de Mesa Dolores Ibarreta

Only a few studies have addressed the cost-effectiveness of pharmacogenetics interventions in healthcare. Lack of health economics data on aspects of pharmacogenetics is perceived as one of the barriers hindering its implementation for improving drug safety. Thus, a recent Institute for Prospective Technological Studies (IPTS) study, entitled 'Pharmacogenetics and pharmacogenomics: state-of-the...

Journal: :Endocrinology 2012
B T Miller C B Ueta V Lau K G Jacomino L M Wasserman Brian W Kim

The type 2 iodothyronine selenodeiodinase (D2) is a critical determinant of local thyroid signaling, converting T(4) to the active form T(3) at the cytoplasmic face of the endoplasmic reticulum, thus supplying the nucleus with T(3) without immediately affecting circulating thyroid hormone levels. Although inhibitors of the cholesterol synthesis/isoprenylation pathway, such as hydroxy-methyl-glu...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید